CAM
GOSS icon

Cormorant Asset Management’s Gossamer Bio GOSS Stock Holding History

Cormorant Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,198,382
Closed -$38.3M – 74
2022
Q3 		$38.3M Buy
3,198,382
+3,000,000
+1,512% +$37.2M 2.68% 11
2022
Q2 		$1.66M Hold
198,382
– – 0.13% 64
2022
Q1 		$1.72M Hold
198,382
– – 0.13% 69
2021
Q4 		$2.24M Hold
198,382
– – 0.13% 69
2021
Q3 		$2.49M Hold
198,382
– – 0.1% 81
2021
Q2 		$1.61M Sell
198,382
-650,000
-77% -$5.64M 0.05% 95
2021
Q1 		$7.85M Hold
848,382
– – 0.17% 81
2020
Q4 		$8.2M Buy
848,382
+600,000
+242% +$5.91M 0.2% 75
2020
Q3 		$3.08M Sell
248,382
-100,943
-29% -$1.34M 0.12% 83
2020
Q2 		$4.54M Buy
349,325
+150,943
+76% +$1.9M 0.17% 72
2020
Q1 		$2.01M Sell
198,382
-101,618
-34% -$1.33M 0.09% 70
2019
Q4 		$4.69M Sell
300,000
-318,129
-51% -$6.41M 0.19% 61
2019
Q3 		$10.4M Sell
618,129
-25,000
-4% -$497K 0.63% 44
2019
Q2 		$14.3M Sell
643,129
-10,000
-2% -$191K 0.82% 38
2019
Q1 		$14.2M Buy
+653,129
New +$13.6M 0.96% 34

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cormorant Asset Management's GOSS Position: Q4 2022 in Review

Cormorant Asset Management sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 3,198,382 shares — an estimated $38.3M sold.

Cormorant Asset Management first reported a position in GOSS in Q1 2019 and held it in 15 quarters. The position peaked at $38.3M in Q3 2022. 120 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Cormorant Asset Management reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Cormorant Asset Management sold 3,198,382 Gossamer Bio shares in Q4 2022, an estimated $38.3M.
  • Cormorant Asset Management first reported a position in Gossamer Bio in Q1 2019 and held it in 15 quarters.
  • Cormorant Asset Management's Gossamer Bio position peaked at $38.3M in Q3 2022.
  • 120 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Cormorant Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.